NeoCOAST-2 trial finds early ctDNA clearance in blood tests linked to improved lung cancer outcomes, potentially guiding ...

Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...

Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, ...

Antibody patterns can signal whether a person will develop inflammatory bowel disease (IBD) up to 10 years before diagnosis.

From whole-genome sequencing to magnetic resonance imaging (MRI) and artificial intelligence (AI)-guided diagnostics, these ...

GLP-1 medications may reduce complications after surgery, with new research linking their use to fewer cardiovascular events ...

New research reveals how autoimmune kidney inflammation develops and identifies an antibody-based strategy that may prevent ...

New research links genomic, transcriptomic, and epigenetic features to treatment response in multiple myeloma.

The U.K. biotech IMU Biosciences will help create a large and detailed immune dataset for 80,000 people in the UK Biobank.

A blood test could help clinicians identify patients with traumatic brain injury (TBI) who may otherwise go undiagnosed.

Kiszala, the CEO and co-founder of intoDNA, to explore how a breakthrough in understanding DNA damage and repair could ...

An experimental bispecific antibody designed to activate selected populations of T cells has produced early tumor responses in patients with advanced cancers, including some whose disease had resisted ...